A comprehensive 4-year survey of adverse drug reactions using a network-based hospital system

Journal of Clinical Pharmacy and Therapeutics

Volumn 37, Issue 6, 2012, Pages 647-651

  Chen, C J ^a   Cheng, C F ^a   Lin, H Y ^a   Hung, S P ^a   Chen, W C ^a   Lin, M S ^a  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

Author keywords

drug allergies; hospital based spontaneous ADR reporting system

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; CEPHALOSPORIN DERIVATIVE; CONTRAST MEDIUM; GASTROINTESTINAL AGENT; IMMUNOGLOBULIN E; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN DERIVATIVE; VACCINE;

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; ARTICLE; CHILD; DRUG HYPERSENSITIVITY; DRUG SURVEILLANCE PROGRAM; FEMALE; HOSPITAL ADMISSION; HOSPITAL PLANNING; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEASLES LIKE RASH; PRESCHOOL CHILD; SCHOOL CHILD; URTICARIA;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; ANAPHYLAXIS; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; FEMALE; HOSPITALS, TEACHING; HUMANS; IMMUNOGLOBULIN E; INFANT; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; PHARMACOVIGILANCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84868378010     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2012.01359.x     Document Type: Article

References (23)

1. World Health Organization. International drug monitoring: the role of the hospital. In: Report of a WHO Meeting on international drug monitoring. Geneva: WHO, 1969.
2. Rawlins M, Thompson W,. Mechanisms of adverse drug reactions. In:, Davies D, ed. Textbook of adverse drug reactions, 4th edn. Oxford, UK: Oxford University Press, 18-45, 1991.
3. Stephens T, Brynner R,. Dark remedy: the impact of thalidomide and its revival as a vital medicine. Cambridge, MA: Perseus Publishing, 2001.
4. Coombs R, Gell PG,. Classification of allergic reactions responsible for clinical hypersensitivity and disease. In:, Gell P, Coombs RR, Lachman PJ, eds. Clinical aspects of immunology. Oxford, UK: Blackwell Scientific Publications, 761-781, 1975.
5. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther, 1981; 30: 239-245.
6. Patterson R, DeSwarte RD, Greenberger PA, Grammer LC, Brown JE, Choy AC,. Drug allergy and protocols for management of drug allergies. Allergy Proc, 1994; 15: 239-264.
7. Lazarou J, Pomeranz BH, Corey PN,. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA, 1998; 279: 1200-1205.
8. Bocquet H, Bagot M, Roujeau JC,. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg, 1996; 15: 250-257.
9. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC,. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol, 1993; 129: 92-96.
10. Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC,. Acute generalized exanthematous pustulosis (AGEP)-a clinical reaction pattern. J Cutan Pathol, 2001; 28: 113-119.
11. Gruchalla RS,. Drug allergy. J Allergy Clin Immunol, 2003; 111: S548-S559.
12. Macy E, Poon KYT,. Self-reported antibiotic allergy incidence and prevalence: age and sex effects. Am J Med, 2009; 122: 778.e1-778.e7.
13. Bigby M, Jick S, Jick H, Arndt K,. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA, 1986; 256: 3358-3363.
14. Gomes E, Cardoso MF, Praca F, Gomes L, Marino E, Demoly P,. Self-reported drug allergy in a general adult Portuguese population. Clin Exp Allergy, 2004; 34: 1597-1601.
15. Kano Y, Shiohara T,. The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug. Immunol Allergy Clin North Am, 2009; 29: 481-501.
16. Gennis MA, Vemuri R, Burns EA, Hill JV, Miller MA, Spielberg SP,. Familial occurrence of hypersensitivity to phenytoin. Am J Med, 1991; 91: 631-634.
17. Rebelo Gomes E, Fonseca J, Araujo L, Demoly P,. Drug allergy claims in children: from self-reporting to confirmed diagnosis. Clin Exp Allergy, 2008; 38: 191-198.
18. Ibia EO, Schwartz RH, Wiedermann BL,. Antibiotic rashes in children: a survey in a private practice setting. Arch Dermatol, 2000; 136: 849-854.
19. Raja AS, Lindsell CJ, Bernstein JA, Codispoti CD, Moellman JJ,. The use of penicillin skin testing to assess the prevalence of penicillin allergy in an emergency department setting. Ann Emerg Med, 2009; 54: 72-77.
20. del Real GA, Rose ME, Ramirez-Atamoros MT, et al. Penicillin skin testing in patients with a history of beta-lactam allergy. Ann Allergy Asthma Immunol, 2007; 98: 355-359.
21. Bernstein JA,. Allergic drug reactions. How to minimize the risks. Postgrad Med, 1995; 98: 159-160, 163- 156.
22. Hung SI, Chung WH, Jee SH, et al. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics, 2006; 16: 297-306.
23. Man CB, Kwan P, Baum L, et al. Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia, 2007; 48: 1015-1018.